Company intelligence / Profile preview
Oncobiomed
Chileoncobiomed.cl ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
TAPCells™ immunotherapy has been applied to more than 300 patients with highly successful results in melanoma and prostate cancer, with clinical trials completed in Phase I and Phase II. Lycellvax is at pre-clinical stage showing safety and efficacy in murine models.
- Therapeutic areas
- Oncology
- Modalities
- Cell therapyBiologic
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
University of Chile (technology licensing)
Beyond the preview
Go deeper on Oncobiomed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oncobiomed.